Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination

As the news of approval of COVID-19 vaccination emerge, neurologists across the globe ponder upon whether to use immunotherapies in patients with Multiple Sclerosis (MS). This paper highlights the mechanism of various disease modifying therapies (DMTs) as well as the recently approved Pfizer and Mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Podury, Sanjiti, Khan, Erum, Tandon, Medha, Jaiswal, Shruti, Sriwastava, Shitiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166521/
https://www.ncbi.nlm.nih.gov/pubmed/34275536
http://dx.doi.org/10.1016/j.jocn.2021.05.063
_version_ 1783701521514364928
author Podury, Sanjiti
Khan, Erum
Tandon, Medha
Jaiswal, Shruti
Sriwastava, Shitiz
author_facet Podury, Sanjiti
Khan, Erum
Tandon, Medha
Jaiswal, Shruti
Sriwastava, Shitiz
author_sort Podury, Sanjiti
collection PubMed
description As the news of approval of COVID-19 vaccination emerge, neurologists across the globe ponder upon whether to use immunotherapies in patients with Multiple Sclerosis (MS). This paper highlights the mechanism of various disease modifying therapies (DMTs) as well as the recently approved Pfizer and Moderna vaccines for COVID-19 as well as guidelines as introduced by National Multiple Sclerosis Society. As their mechanisms counteract each other at the molecular level, we believe further evidence and data might lay the foundation to formulate much needed recommendations for the usage of these medications while vaccinating MS patients on DMTs.
format Online
Article
Text
id pubmed-8166521
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-81665212021-06-01 Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination Podury, Sanjiti Khan, Erum Tandon, Medha Jaiswal, Shruti Sriwastava, Shitiz J Clin Neurosci Short Communication As the news of approval of COVID-19 vaccination emerge, neurologists across the globe ponder upon whether to use immunotherapies in patients with Multiple Sclerosis (MS). This paper highlights the mechanism of various disease modifying therapies (DMTs) as well as the recently approved Pfizer and Moderna vaccines for COVID-19 as well as guidelines as introduced by National Multiple Sclerosis Society. As their mechanisms counteract each other at the molecular level, we believe further evidence and data might lay the foundation to formulate much needed recommendations for the usage of these medications while vaccinating MS patients on DMTs. Elsevier Ltd. 2021-08 2021-06-01 /pmc/articles/PMC8166521/ /pubmed/34275536 http://dx.doi.org/10.1016/j.jocn.2021.05.063 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Podury, Sanjiti
Khan, Erum
Tandon, Medha
Jaiswal, Shruti
Sriwastava, Shitiz
Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title_full Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title_fullStr Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title_full_unstemmed Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title_short Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
title_sort evolution of our understanding of ms-covid-19 interactions and concerns for vaccination
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166521/
https://www.ncbi.nlm.nih.gov/pubmed/34275536
http://dx.doi.org/10.1016/j.jocn.2021.05.063
work_keys_str_mv AT podurysanjiti evolutionofourunderstandingofmscovid19interactionsandconcernsforvaccination
AT khanerum evolutionofourunderstandingofmscovid19interactionsandconcernsforvaccination
AT tandonmedha evolutionofourunderstandingofmscovid19interactionsandconcernsforvaccination
AT jaiswalshruti evolutionofourunderstandingofmscovid19interactionsandconcernsforvaccination
AT sriwastavashitiz evolutionofourunderstandingofmscovid19interactionsandconcernsforvaccination

Ejemplares similares